Search for: "OTSUKA PHARMACEUTICAL COMPANY LTD" Results 1 - 15 of 15
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2018, 12:20 pm by Tom Lamb
The drug companies responsible for Rexulti in the US are Otsuka Pharmaceutical Co., Ltd. [read post]
22 May 2018, 12:20 pm by Tom Lamb
The drug companies responsible for Rexulti in the US are Otsuka Pharmaceutical Co., Ltd. [read post]
5 Jul 2015, 4:18 am by Mark Summerfield
’  I explained that Swiss-type claims are treated as if they cover any and every method of making a medicament of any kind that includes the compound as an active ingredient, and with the intention of it being used to treat the new condition.By sheer coincidence, on 29 June 2015 Justice Yates, in the Federal Court of Australia, handed down a ruling in Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) [2015] FCA 634, in which he has a great… [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
In Neurim Pharmaceuticals (1991) Ltd and another company v Generics UK Ltd and another [2020] EWHC 3270 (Pat), Neurim was successful on all issues. [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
The first instances of the cases were invalidation trials at the JPO filed by a number of generic companies[1](i) Kyowa Pharmaceutical Industry Co., Ltd., (ii) Nichi-Iko Pharmaceutical Co., Ltd., (iii) Nipro Corporation, (iv) Towa Pharmaceutical Co., Ltd., (v) Meiji Seika Pharma Co., Ltd. and (vi) Ohara … Continue reading against a medical use patent of Otsuka Pharmaceutical Co., Ltd. [read post]
14 May 2008, 9:35 pm
Snecama Aerospace Industry (Suzhou) Co., Ltd. and Messier-Dowty Aerospace (Suzhou) Co., Ltd., the two subsidiaries of the French-owned Safran Corporation and manufacturers of components parts of aircraft engines and landing gears, celebrated official opening on April 7 in SIP Suzhou Otsuka Pharmaceutical Co., Ltd., invested by the Japanese-owned Otsuka Pharmaceutical Co, held a foundation laying ceremony in SIP on April 17. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Granted Anoop K Joy 1251/KOL/2006 OTSUKA PHARMACEUTICAL CO. [read post]
18 Nov 2016, 12:44 am by John Collins
Swiss Claims – Direct Infringement In the Australian proceedings, the Court affirmed Justice Yates’ approach in Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 4) (2015) 113 IPR 191, namely that the question of infringement of Swiss type claims was viewed through the prism of paragraph (b) of the definition of “exploit” in Schedule 1 of the Patents Act, which extends infringement to the use of the claimed method via a product… [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd: (Afro-IP) … [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]